295 related articles for article (PubMed ID: 15491235)
1. Behavioral and psychological symptoms in patients with dementia as a target for pharmacotherapy with risperidone.
Rabinowitz J; Katz IR; De Deyn PP; Brodaty H; Greenspan A; Davidson M
J Clin Psychiatry; 2004 Oct; 65(10):1329-34. PubMed ID: 15491235
[TBL] [Abstract][Full Text] [Related]
2. Factor analysis of the Cohen-Mansfield Agitation Inventory in three large samples of nursing home patients with dementia and behavioral disturbance.
Rabinowitz J; Davidson M; De Deyn PP; Katz I; Brodaty H; Cohen-Mansfield J
Am J Geriatr Psychiatry; 2005 Nov; 13(11):991-8. PubMed ID: 16286443
[TBL] [Abstract][Full Text] [Related]
3. Treating behavioral and psychological symptoms in patients with psychosis of Alzheimer's disease using risperidone.
Rabinowitz J; Katz I; De Deyn PP; Greenspan A; Brodaty H
Int Psychogeriatr; 2007 Apr; 19(2):227-40. PubMed ID: 16879763
[TBL] [Abstract][Full Text] [Related]
4. A randomized placebo-controlled trial of risperidone for the treatment of aggression, agitation, and psychosis of dementia.
Brodaty H; Ames D; Snowdon J; Woodward M; Kirwan J; Clarnette R; Lee E; Lyons B; Grossman F
J Clin Psychiatry; 2003 Feb; 64(2):134-43. PubMed ID: 12633121
[TBL] [Abstract][Full Text] [Related]
5. Comparative efficacy of risperidone versus haloperidol on behavioural and psychological symptoms of dementia.
Suh GH; Greenspan AJ; Choi SK
Int J Geriatr Psychiatry; 2006 Jul; 21(7):654-60. PubMed ID: 16821257
[TBL] [Abstract][Full Text] [Related]
6. Management of agitation, aggression, and psychosis associated with dementia: a pooled analysis including three randomized, placebo-controlled double-blind trials in nursing home residents treated with risperidone.
De Deyn PP; Katz IR; Brodaty H; Lyons B; Greenspan A; Burns A
Clin Neurol Neurosurg; 2005 Oct; 107(6):497-508. PubMed ID: 15922506
[TBL] [Abstract][Full Text] [Related]
7. The efficacy and safety of risperidone in the treatment of psychosis of Alzheimer's disease and mixed dementia: a meta-analysis of 4 placebo-controlled clinical trials.
Katz I; de Deyn PP; Mintzer J; Greenspan A; Zhu Y; Brodaty H
Int J Geriatr Psychiatry; 2007 May; 22(5):475-84. PubMed ID: 17471598
[TBL] [Abstract][Full Text] [Related]
8. Risperidone for psychosis of Alzheimer's disease and mixed dementia: results of a double-blind, placebo-controlled trial.
Brodaty H; Ames D; Snowdon J; Woodward M; Kirwan J; Clarnette R; Lee E; Greenspan A
Int J Geriatr Psychiatry; 2005 Dec; 20(12):1153-7. PubMed ID: 16315159
[TBL] [Abstract][Full Text] [Related]
9. Galantamine versus risperidone for agitation in people with dementia: a randomized, twelve-week, single-center study.
Freund-Levi Y; Bloniecki V; Auestad B; Tysen Bäckström AC; Lärksäter M; Aarsland D
Dement Geriatr Cogn Disord; 2014; 38(3-4):234-44. PubMed ID: 24969380
[TBL] [Abstract][Full Text] [Related]
10. Scales to assess efficacy and safety of pharmacologic agents in the treatment of behavioral and psychological symptoms of dementia.
De Deyn PP; Wirshing WC
J Clin Psychiatry; 2001; 62 Suppl 21():19-22. PubMed ID: 11584983
[TBL] [Abstract][Full Text] [Related]
11. Comparison of risperidone and placebo for psychosis and behavioral disturbances associated with dementia: a randomized, double-blind trial. Risperidone Study Group.
Katz IR; Jeste DV; Mintzer JE; Clyde C; Napolitano J; Brecher M
J Clin Psychiatry; 1999 Feb; 60(2):107-15. PubMed ID: 10084637
[TBL] [Abstract][Full Text] [Related]
12. A double-blind randomised comparison of risperidone and haloperidol in the treatment of behavioural and psychological symptoms in Chinese dementia patients.
Chan WC; Lam LC; Choy CN; Leung VP; Li SW; Chiu HF
Int J Geriatr Psychiatry; 2001 Dec; 16(12):1156-62. PubMed ID: 11748775
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of neuropsychiatric symptoms in a large sample of Dutch nursing home patients with dementia.
Zuidema SU; Derksen E; Verhey FR; Koopmans RT
Int J Geriatr Psychiatry; 2007 Jul; 22(7):632-8. PubMed ID: 17136713
[TBL] [Abstract][Full Text] [Related]
14. A randomized trial of risperidone, placebo, and haloperidol for behavioral symptoms of dementia.
De Deyn PP; Rabheru K; Rasmussen A; Bocksberger JP; Dautzenberg PL; Eriksson S; Lawlor BA
Neurology; 1999 Sep; 53(5):946-55. PubMed ID: 10496251
[TBL] [Abstract][Full Text] [Related]
15. A randomized, double-blind, crossover comparison of risperidone and haloperidol in Korean dementia patients with behavioral disturbances.
Suh GH; Son HG; Ju YS; Jcho KH; Yeon BK; Shin YM; Kee BS; Choi SK
Am J Geriatr Psychiatry; 2004; 12(5):509-16. PubMed ID: 15353389
[TBL] [Abstract][Full Text] [Related]
16. Risperidone for the treatment of behavioral and psychological symptoms of dementia.
Tune LE
J Clin Psychiatry; 2001; 62 Suppl 21():29-32. PubMed ID: 11584986
[TBL] [Abstract][Full Text] [Related]
17. A double-blind comparison of citalopram and risperidone for the treatment of behavioral and psychotic symptoms associated with dementia.
Pollock BG; Mulsant BH; Rosen J; Mazumdar S; Blakesley RE; Houck PR; Huber KA
Am J Geriatr Psychiatry; 2007 Nov; 15(11):942-52. PubMed ID: 17846102
[TBL] [Abstract][Full Text] [Related]
18. Antipsychotic treatment of psychosis and agitation in the elderly.
Daniel DG
J Clin Psychiatry; 2000; 61 Suppl 14():49-52. PubMed ID: 11154017
[TBL] [Abstract][Full Text] [Related]
19. Quetiapine versus risperidone in elderly patients with behavioural and psychological symptoms of dementia: efficacy, safety and cognitive function.
Rainer M; Haushofer M; Pfolz H; Struhal C; Wick W
Eur Psychiatry; 2007 Sep; 22(6):395-403. PubMed ID: 17482432
[TBL] [Abstract][Full Text] [Related]
20. Report on an open-label prospective study of divalproex sodium for the behavioral and psychological symptoms of dementia as monotherapy and in combination with second-generation antipsychotic medication.
Forester B; Vanelli M; Hyde J; Perez R; Ahokpossi C; Sribney W; Adkison L
Am J Geriatr Pharmacother; 2007 Sep; 5(3):209-17. PubMed ID: 17996660
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]